UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations.
The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.
Financial Data
-
31st Dec 17 Source: CRO
- €163 million turnover
-
€12.2 million
profit - 1 employees
-
31st Dec 16 Source: CRO
- €167.1 million turnover
-
-€10.4 million
profit - 44 employees
- 9 more years available »
Ranking
By Turnover
(€163 million)- 358th in Top Companies
- 40th in Health
- 41st in Pharma
By Employees
(1)- 986th in Top Companies
- 98th in Health
- 84th in Pharma
-
- 1
- €163 million
Employees
- Steve Turley CEO/Managing Director
Latest News
- 5:11pm Trinity Biotech reports drop in revenues as it books €5.1m tax charge
- 4:00pm Facebook to allow users control data websites share with social network
- 2:57pm Belgian Ryanair unions tell members to refuse to staff flights hit by Portuguese strike
- 1:21pm Chinese FDI to Ireland jumps 75% as it bucks global trend
- 1:00pm Ryanair counsel says pilots’ position on 2018 agreement is ‘extraordinary’